Cite
HARVARD Citation
Spinazzi, E. et al. (2022). Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial. Lancet oncology. 23 (11), pp. 1409-1418. [Online].